+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Epigenetic Regulation of Cancer - Part A. International Review of Cell and Molecular Biology Volume 380

  • Book

  • August 2023
  • Region: Global
  • Elsevier Science and Technology
  • ID: 5850368

Epigenetic Regulation of Cancer - Part A, Volume 380 in the International Review of Cell and Molecular Biology series, presents content from various experts in epigenetics who cover multiple facets of cancer-associated epigenetic alterations, including the impact of epigenetic deregulation in all steps of oncogenesis as well as promising strategies to therapeutically target cancer-associated epigenetic deregulation. Specific chapters cover Epigenetic regulation of epithelial-mesenchymal transition during cancer development, Novel insights into DNA methylation-based epigenetic regulation of breast tumor angiogenesis, Super-enhancer landscape rewiring in cancer: The epigenetic control at distal sites, Non-coding RNAs in the epigenetic landscape of Cutaneous T-cell lymphoma, and much more.

Please Note: This is an On Demand product, delivery may take up to 11 working days after payment has been received.

Table of Contents

1. Epigenetic regulation of epithelial-mesenchymal transition during cancer development Sunisa Yoodee and Visith Thongboonkerd 2. Novel insights into DNA methylation-based epigenetic regulation of breast tumor angiogenesis Sharath Mohan Bhat, Palla Ranga Prasad, and Manjunath B. Joshi 3. Super-enhancer landscape rewiring in cancer: The epigenetic control at distal sites Eros Di Giorgio, Roberta Benetti, Emanuela Kerschbamer, Luigi Xodo, and Claudio Brancolini 4. Non-coding RNAs in the epigenetic landscape of Cutaneous T-cell lymphoma Monaza Adeeb, Lubna Therachiyil, Safwan Moton, Joerg Buddenkotte, Majid Ali Alam, Shahab Uddin, Martin Steinhoff, Aamir Ahmad 5. Epigenetic mechanism of therapeutic resistance and potential of epigenetic therapeutics in chemorefractory prostate cancer Priti Roy, and Kamaleshwar P. Singh 6. Epigenetic inhibitors and their role in cancer therapy Nouha Abdelaziz, Lubna Therachiyil, Hana Sadida, Ateeque M. Ali, Omar S. Khan, Mayank Singh, Abdul Q Khan, Ammira Al-Shabeeb Akil, Ajaz A. Bhat, Shahab Uddin